Oncology PracticeFDA approves in-home breast cancer treatmentJune 30, 2020Breast CancerMetastatic Breast Cancer
Hematology NewsCOVID-19: Medicare data show long hospital stays, disparitiesJune 24, 2020COVID-19 Updates
Hematology NewsFDA approves selinexor for relapsed/refractory DLBCLJune 23, 2020DLBCLLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsFDA gives thumbs up to tazemetostat for follicular lymphomaJune 19, 2020Lymphoma & Plasma Cell DisordersB Cell LymphomaFollicular Lymphoma
Oncology PracticeGardasil-9 approved for prevention of head and neck cancersJune 16, 2020Head & Neck/Thyroid CancersPreventive Care
Oncology PracticeNivolumab approved to treat esophageal squamous cell carcinomaJune 11, 2020Head & Neck/Thyroid Cancers
Oncology PracticeAmericans avoided emergency departments early in the pandemicJune 3, 2020COVID-19 Updates
Oncology PracticeFDA approves ramucirumab-erlotinib combo for metastatic NSCLCJune 1, 2020Lung Cancer
Oncology PracticeFDA approves mAb combo for hepatocellular carcinomaJune 1, 2020GastroenterologyGastrointestinal Cancer
Oncology PracticeFDA approves olaparib for certain metastatic prostate cancersMay 21, 2020Genitourinary CancerProstate Cancer
Oncology PracticeFirst PARP inhibitor approved for metastatic prostate cancerMay 19, 2020Genitourinary CancerProstate Cancer
